Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
- To test the hypothesis that supplementation of DHEA for at least twelve weeks prior to
and during ovarian stimulation increases oocyte quantity (number of oocytes retrieved)
and oocyte quality (clinical pregnancy rates and molecular markers) following IVF and
IVF/ICSI treatment.
- To evaluate the feasibility of conducting a large multicentre trial